DOCSLIB.ORG

Novobiocin and Coumermycin Inhibit DNA Supercoiling Catalyzed by DNA Gyrase (Escherichia Coli/Colicin El DNA Replication/Phage a DNA) MARTIN GELLERT, MARY H

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Novobiocin and Coumermycin Inhibit DNA Supercoiling Catalyzed by DNA Gyrase (Escherichia Coli/Colicin El DNA Replication/Phage a DNA) MARTIN GELLERT, MARY H Proc. Natl. Acad. Sci. USA Vol. 73, No. 12, pp. 4474-4478, December 1976 Biochemistry Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase (Escherichia coli/colicin El DNA replication/phage A DNA) MARTIN GELLERT, MARY H. O'DEA, TATEO ITOH, AND JUN-ICHI TOMIZAWA Laboratory of Molecular Biology, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014 Communicated by Gary Felsenfeld, October 6, 1976 ABSTRACT Novobiocin and coumermycin are known to Among several spontaneous coumermycin-resistant mutants inhibit the replication of DNA in Escherichia coli. We show that of NI708 which were tested, all gave resistant extracts for the these drugs inhibit the supercoiling of DNA catalyzed by E. coli DNA gyrase, a recently discovered enzyme that introduces in vitro Col El DNA replication system. One of these mutants, negative superhelical turns into covalently circular DNA. The N1741, was chosen for further work because of its good growth. activity of DNA gyrase purified from a coumermycin-resistant This strain apparently has a partial reversion of the permeability mutant strain is resistant to both drugs. The inhibition by no- mutation of N1708. The couR mutation of NI741 was trans- vobiocin of colicin El plasmid DNA replication in a cell-free ferred, by phage P1 cotransduction with dnaA+, to strain system is partially relieved by adding resistant DNA gyrase. CRT46 dnaA (10). The resulting strain, N1748, was used as a Both in the case of colicin El DNA in E. coli extracts and of phage X DNA in whole cells, DNA molecules which are con- source for purification of drug-resistant DNA gyrase. DNA verted to the covalently circular form in the presence of coum- gyrase sensitive to both novobiocin and coumermycin was ermycin remain relaxed, instead of achieving their normal su- isolated from N99 recB21 (7). Strain N1071(Xind-) (11) was percoiled conformation. We conclude that DNA gyrase controls used for experiments of superinfection by phage X, and strain the supercoiling of DNA in E. coli. YSl (8) for testing supercoiling of Col El DNA in extracts. Of these strains, the coumermycin-resistant isolates NI741 Novobiocin and the related drug coumermycin are preferential and N1748 are able to grow in liquid culture containing 60 inhibitors of DNA replication in intact Escherichia coli cells gg/ml of coumermycin; growth of the other strains is blocked (1, 2). In toluenized cells of E. coli, these drugs inhibit repli- by 15 gg/ml of the drug. cative DNA synthesis but not repair synthesis (3, 4). They are Chemicals. Novobiocin was obtained from Sigma Chemical also effective inhibitors in cell-free systems for the replication Co. Samples of coumermycin A1 (referred to as coumermycin of colicin El (Col El) DNA (5) and of phage OX174 replicative throughout this paper) were gifts from W. F. Minor (Bristol form DNA (6), but they do not inhibit the synthesis of the Laboratories) and J. Davies (University of Wisconsin). Sources complementary strand of OX174 single-stranded DNA (6). of other materials have been described previously (7, 8, 12). Coumermycin-resistant mutants of E. coli have been isolated, Methods. Procedures for the assay of Col El DNA replica- and the mutation has been mapped near the dnaA locus (2). tion (8, 12, 13), and for the purification and assay of DNA gy- An enzyme, DNA gyrase, that introduces negative su- rase (7), have been described before. DNA gyrase from the perhelical turns into double-stranded closed circular DNA, has coumermycin-resistant strain NI748 was purified by the same recently been purified from E. coli (7). In this paper, we show method. Fraction IV enzyme was used for all experiments. that DNA gyrase activity in vitro as well as in vivo is specifically DNA Preparations. Relaxed and intracellularly supercoiled inhibited by coumermycin and novobiocin. Col El DNA samples were prepared as described (7, 8). Relaxed covalently-circular phage X DNA was prepared by sealing with MATERIALS AND METHODS DNA ligase as described (7). Bacterial Strains. Coumermycin-resistant E. coli mutants used for the present study were isolated by a two-step proce- RESULTS dure. The starting strain, E. coli NT525 pnp rns end strA, was constructed by recombination between EB5004 end (8) and a Inhibition of DNA gyrase activity by novobiocin and thy derivative of SK107 pnp rns strA polA+, the parental strain coumermycin of SK108 polA (9), provided by S. Kushner. Strain NT525, like For visualizing the activity of DNA gyrase, we have made use most other E. coli K12 strains, is quite resistant to novobiocin of the difference in mobility between relaxed and supercoiled (grows on tryptone agar containing 600 ,g/ml of novobiocin) closed-circular Col El DNA on agarose gel electrophoresis (7, because of low permeability to the drug (W. G. Coleman, 14). As is shown in Fig. 1, intracellularly supercoiled Col El personal communication). Strain NI708, with increased sensi- DNA (Fig. la) has roughly twice the mobility of relaxed tivity to novobiocin, was constructed by mating NT525 with closed-circular Col El DNA (Fig. lb). When relaxed closed- strain CL2, an HfrH derivative which carries a mutation con- circular Col El DNA was incubated with DNA gyrase purified ferring increased permeability to a number of drugs (W. G. from the coumermycin-sensitive strain N99 recB, most of the Coleman, personal communication). Mutants of NI708 with DNA was converted to a form with the increased mobility of various extents of increased resistance to novobiocin were iso- supercoiled Col El DNA (Fig. 1c). This reaction was progres- lated but all the isolates tested turned out to be resistant due to sively inhibited by increasing concentrations of novobiocin (Fig. reduced permeability. The selection was therefore repeated ld-h). At low drug concentrations (0.3-1.0 ,ug/ml), interme- with coumermycin, which is apparently indifferent to the diate DNA species were seen which had lesser degrees of su- permeability barrier for novobiocin (unpublished results). percoiling (15); at 3 ,ug/mi of novobiocin the reaction was totally inhibited. By contrast, the activity of DNA gyrase purified from Abbreviation: Col El, colicin El. the coumermycin-resistant strain N1748 was unaffected by all 4474 Downloaded by guest on October 2, 2021 Acad. Sci. USA 73 (1976) 4475 Biochemistry: Gellert et al. Proc. Natl. Table 1. Inhibition of Col El DNA replication by i j k I m n o p a b c d e f g h novobiocin and complementation by resistant DNA gyrase dTMP Source incor- of porated extract Additions (pmol) NT525 None 3.8 Sensitive DNA gyrase 3.9 Resistant DNA gyrase 3.0 Novobiocin 0.4 Novobiocin + sensitive DNA gyrase 0.3 Novobiocin + resistant DNA gyrase 1.1 N1741 None 3.4 FIG. 1. Novobiocin sensitivity of DNA gyrase from sensitive and Sensitive DNA gyrase 3.4 resistant E. coli strains. Channel (a) intracellularly supercoiled Col Resistant DNA gyrase 3.7 El DNA; (b) relaxed Col El DNA; (c-h) relaxed Col El DNA incu- 3.1 and Novobiocin bated with DNA gyrase purified from strain N99 recB21 (0.65 ,g) + DNA gyrase 2.0 of novobiocin; (i-n) relaxed Col El DNA in- Novobiocin sensitive varying concentrations Novobiocin + resistant DNA gyrase 3.7 cubated with DNA gyrase purified from strain NI748 (0.40 Mg) and varying concentrations of novobiocin. Novobiocin concentrations (f) Extracts were prepared as described from strain NT525 (coumer- were: (c) and (i), none; (d) and U), 0.3 Mg/ml; (e) and (k), 1 Mg/ml; and mycin-sensitive) and from strain NI741 (coumermycin-resistant) and (1), 3 Mg/ml; (g) and (m), 10 Mg/ml; (h) and (n), 30 Mg/ml. In (o)' The procedure for N99 recB and 0.20 Mg of DNA (8), except that the cells were cultured at 300. (p), 0.33 ,g of DNA gyrase from strain DNA replication was essentially as described were mixed and assayed in the absence (o) the assay of Col El gyrase from strain NI748 (12). The reaction mixtures (30 Il) contained 10 ,g/ml of intracel- and presence (p) of 3 ,g/ml novobiocin. lularly supercoiled Col El DNA, 25 MM each of four deoxyribonu- cleoside triphosphates (dNTPs), 400 ,M ATP, 200 AM each of other 1 NAD, 41 mM potas- Fig. lo and p show that ribonucleoside triphosphates (rNTPs), mM these levels of novobiocin (Fig. li-n). 33 mM KCl, 25 mM (NH4)2SO4, 8 mM novobiocin resistance on sium phosphate at pH 7.1, the resistant enzyme cannot confer MgCl2, 60MVM dithiothreitol, 60MgM Na3EDTA, 330 Mg/ml of bovine sensitive DNA gyrase; a mixture of the two enzymes showed plasma albumin, 10% (vol/vol) glycerol, and 2 mM spermidine. The more than 50% inhibition by novobiocin. Coum- reaction mixture contained 10 ,ul (100 Ag of protein) of extract. evidence of was 500 cpm/pmol. DNA ermycin also inhibited DNA gyrase activity (data not shown); Specific radioactivity of [a-32P]dTTP gyrase (fraction IV) was concentrated by precipitation with am- this drug was effective at roughly 10-fold lower concentrations a concentration of 1-2 in- monium sulfate and was resuspended at than novobiocin. DNA gyrase purified from N99 recB was mg/ml in 50% (vol/vol) glycerol, 0.15 M potassium phosphate at hibited more than 90% by 0.3 ,ug/ml of coumermycin; DNA pH 6.8, 2.5 mg/ml of bovine plasma albumin, 0.5 mM Na3EDTA, from the resistant mutant was unaffected by concen- and 0.5 mM dithiothreitol. Novobiocin-sensitive DNA gyrase (from gyrase DNA gyrase (from trations of the drug up to 1 gg/ml. strain N99 recB2l) and novobiocin-resistant strain N1748) were added in the amounts of 5.3 Mg and 6.3 Mg per Inhibition of in vitro Col El DNA replication by assay, respectively.
Load more

Recommended publications
  • Introduction of Human Telomerase Reverse Transcriptase to Normal Human Fibroblasts Enhances DNA Repair Capacity
    Vol. 10, 2551–2560, April 1, 2004 Clinical Cancer Research 2551 Introduction of Human Telomerase Reverse Transcriptase to Normal Human Fibroblasts Enhances DNA Repair Capacity Ki-Hyuk Shin,1 Mo K. Kang,1 Erica Dicterow,1 INTRODUCTION Ayako Kameta,1 Marcel A. Baluda,1 and Telomerase, which consists of the catalytic protein subunit, No-Hee Park1,2 human telomerase reverse transcriptase (hTERT), the RNA component of telomerase (hTR), and several associated pro- 1School of Dentistry and 2Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California teins, has been primarily associated with maintaining the integ- rity of cellular DNA telomeres in normal cells (1, 2). Telomer- ase activity is correlated with the expression of hTERT, but not ABSTRACT with that of hTR (3, 4). Purpose: From numerous reports on proteins involved The involvement of DNA repair proteins in telomere main- in DNA repair and telomere maintenance that physically tenance has been well documented (5–8). In eukaryotic cells, associate with human telomerase reverse transcriptase nonhomologous end-joining requires a DNA ligase and the (hTERT), we inferred that hTERT/telomerase might play a DNA-activated protein kinase, which is recruited to the DNA role in DNA repair. We investigated this possibility in nor- ends by the DNA-binding protein Ku. Ku binds to hTERT mal human oral fibroblasts (NHOF) with and without ec- without the need for telomeric DNA or hTR (9), binds the topic expression of hTERT/telomerase. telomere repeat-binding proteins TRF1 (10) and TRF2 (11), and Experimental Design: To study the effect of hTERT/ is thought to regulate the access of telomerase to telomere DNA telomerase on DNA repair, we examined the mutation fre- ends (12, 13).
    [Show full text]
  • 1057-1064, 1984 the Effect of Pipemidic Acid on The
    Microbiol. Immunol. Vol. 28 (9), 1057-1064, 1984 The Effect of Pipemidic Acid on the Growth of a Stable L-Form of •ôNH•ôStaphylococcus aureus•ôNS•ô Kunihiko YABU,*,1 Hiromi ToMizu,1 and Yayoi KANDA2 1 Department of Biology, Hokuriku University School of Pharmacy, Kanazawa-machi, Kanazawa, Ishikawa ,920-11, and 2Department of Microbiology, Teikyo University School of Medicine, Kaga 2-chome, Ilabashi-ku, Tokyo 173 (Accepted for publication, June 12, 1984) Bacterial L-forms usually display spherical forms in an osmotically protective medium and seem to lack the typical binary fission process of cellular division ob servedin most bacteria (7). Although various modes of replication, such as budding binary fission, and release of elementary bodies from large bodies have been observed by light and electron microscopy (2, 5, 16), little is known about the processes involved in replication of L-forms. In the course of an experiment designed to test the effect of DNA synthesis inhibitors on the growth of a stable L-form of •ôNH•ôStaphylococcus•ôNS•ôaureus which grows in liquid medium, it was found that pipemidic acid, a synthetic antibacterial agent structurally related to nalidixic acid (13), induced a marked morphological altera tionat growth inhibitory concentrations. This study was initiated in an attempt to clarify the mechanism of replication of stable L-forms by analyzing the mor phologicalalteration caused by pipemidic acid. The stable L-form used was isolated as follows. S. •ôNH•ôaureus•ôNS•ôFDA 209P was grown in 10ml of Brain Heart Infusion broth (Difco) at 37C. The culture grown at 5•~105 colony-forming units (CFU) per ml was washed with saline by filtration and suspended in saline containing 100ƒÊg of N-methyl-N'-nitro-N-nitrosoguanidine per nil.
    [Show full text]
  • Dissertation
    DISSERTATION FOLATE PATHWAY INHIBITOR RESISTANCE MECHANISMS IN BURKHOLDERIA PSEUDOMALLEI Submitted by Nicole L. Podnecky Department of Microbiology, Immunology and Pathology In partial fulfillment of the requirements For the Degree of Doctor of Philosophy Colorado State University Fort Collins, Colorado Fall 2013 Doctoral Committee: Advisor: Herbert P. Schweizer Steven W. Dow Richard A. Slayden Laurie A. Stargell ABSTRACT FOLATE PATHWAY INHIBITOR RESISTANCE MECHANISMS IN BURKHOLDERIA PSEUDOMALLEI Antimicrobials are invaluable tools used to facilitate the treatment of infectious diseases. Their use has saved millions of lives since their introduction in the early 1900’s. Unfortunately, due to the increased incidence and dispersal of antimicrobial resistance determinants, many of these drugs are no longer efficacious. This greatly limits the options available for treatment of serious bacterial infections, including melioidosis, which is caused by Burkholderia pseudomallei, a Gram-negative saprophyte. This organism is intrinsically resistant to many antimicrobials. Additionally, there have been reports of B. pseudomallei isolates resistant to several of the antimicrobials currently used for treatment, including the trimethoprim and sulfamethoxazole combination, co-trimoxazole. The overarching goal of this project was to identify and characterize mechanisms of trimethoprim and sulfamethoxazole resistance in clinical and environmental isolates, as well as in laboratory induced mutants. Prior to these studies, very little work has been done to identify and characterize the mechanisms by which B. pseudomallei strains are or could become resistant to folate-pathway inhibitors, specifically trimethoprim and sulfamethoxazole. During the initial phases of these studies, we determined the antimicrobial susceptibilities of a large collection of clinical and environmental isolates from Thailand and Australia (n = 65).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0115729 A1 Qin Et Al
    US 201201.15729A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0115729 A1 Qin et al. (43) Pub. Date: May 10, 2012 (54) PROCESS FOR FORMING FILMS, FIBERS, Publication Classification AND BEADS FROM CHITNOUS BOMASS (51) Int. Cl (75) Inventors: Ying Qin, Tuscaloosa, AL (US); AOIN 25/00 (2006.01) Robin D. Rogers, Tuscaloosa, AL A6II 47/36 (2006.01) AL(US); (US) Daniel T. Daly, Tuscaloosa, tish 9.8 (2006.01)C (52) U.S. Cl. ............ 504/358:536/20: 514/777; 426/658 (73) Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF 57 ABSTRACT ALABAMA, Tuscaloosa, AL (US) (57) Disclosed is a process for forming films, fibers, and beads (21) Appl. No.: 13/375,245 comprising a chitinous mass, for example, chitin, chitosan obtained from one or more biomasses. The disclosed process (22) PCT Filed: Jun. 1, 2010 can be used to prepare films, fibers, and beads comprising only polymers, i.e., chitin, obtained from a suitable biomass, (86). PCT No.: PCT/US 10/36904 or the films, fibers, and beads can comprise a mixture of polymers obtained from a suitable biomass and a naturally S3712). (4) (c)(1), Date: Jan. 26, 2012 occurring and/or synthetic polymer. Disclosed herein are the (2), (4) Date: an. AO. films, fibers, and beads obtained from the disclosed process. O O This Abstract is presented solely to aid in searching the sub Related U.S. Application Data ject matter disclosed herein and is not intended to define, (60)60) Provisional applicationpp No. 61/182,833,sy- - - s filed on Jun.
    [Show full text]
  • M1224-100 Thermostable Rnase H
    BioVision 03/17 For research use only Thermostable RNAse H CATALOG NO.: M1224-100 10X THERMOSTABLE RNAse H REACTION BUFFER: 500 mM Tris-HCl, 1000 mM NaCl, AMOUNT: 500 U (100 µl) 100 mM MgCl2, pH 7.5 PRODUCT SOURCE: Recombinant E. coli REACTION CONDITIONS: Use 1X Thermostable RNAse H Reaction Buffer and incubate CONCENTRATION: 100 U/µl at a chosen temperature between 65°C and 95°C (enzyme half-life is 2 hours at 70°C and 30 minutes at 95°C). FORM: Liquid. Enzyme supplied with 10X Reaction Buffer COMPONENTS: Product Name Size Part. No. Thermostable RNAse H (5 U/μl) 100 µl M1224-100-1 10X Thermostable RNAse Reaction Buffer 500 µl M1224-100-2 DESCRIPTION: Thermostable RNAse H (Ribonuclease H) is an endoribonuclease that specifically hydrolyzes the phosphodiester bonds of RNA strands in RNA-DNA hybrids. Unlike E. coli RNAse H which is inactivated at temperatures above 55°C, Thermostable RNase H can withstand much higher temperatures. These higher temperatures allow for higher hybridization stringency for RNA-DNA heteroduplexes resulting in more specific hydrolysis of RNA. Thermostable RNase H has optimal activity above 65°C and is active up to 95°C making it useful for a broad range of applications. APPLICATIONS: 1. High-stringency hybrid selection and mapping of mRNA structure 2. Removal of mRNA prior to synthesis of second strand cDNA 3. Removal of the poly(A) sequences from mRNA in the presence of oligo (dT) 4. Directed cleavage of RNA RELATED PRODUCTS: STORAGE CONDITIONS: Store at -20°C. Avoid repeated freeze-thaw cycles of all E.
    [Show full text]
  • Resistance Pattern of Coagulase Positive Staphylococcus Aureus Clinical Isolates from Asir Region, Kingdom of Saudi Arabia
    Journal of Microbiology and Antimicrobials Vol. 3(4), pp. 102-108, April 2011 Available online http://www.academicjournals.org/JMA ISSN 2141-2308 ©2011 Academic Journals Full Length Research Paper Resistance pattern of coagulase positive Staphylococcus aureus clinical isolates from Asir region, Kingdom of Saudi Arabia Mohamed E. Hamid Department of Microbiology, College of Medicine, King Khalid University, P. O. Box 641, Abha, Kingdom of Saudi Arabia. E-mail: [email protected]. Accepted 6 April, 2011 The objectives of this study were to determine the prevalence of methicillin resistant coagulase positive Staphlococcus aureus (MRSA) infections in two major hospitals in Asir region, Kingdom of Saudi Arabia and to compare it with the community-acquired infections. Two hundreds and ten coagulase positive S. aureus recovered from 9831 specimens from various infections at Asir Central Hospital and Abha General Hospital, KSA (Kingdom of Saudi Arabia), were tested against 44 commonly used antibacterial agents. One hundred of the isolates were from hospital-acquired infections, 100 from community-acquired infections and 10 isolates were collected from the hospital environment. All isolates were found resistant to aztreonam, colistin, mecillinam, metronidazole, polymyxin B and nalidixic acid but were sensitive to vancomycin, nitrofurantoin and novobiocin. Various levels of resistant were recorded for the remaining antibiotics. High resistance to antimicrobial agents was detected among hospital acquired infections compared to community acquired infections (p<0.01). The resistance rates of S. aureus to antimicrobial agents among hospital acquired infections isolates were significantly higher (p<0.05) than community acquired infections. This implies that hospital environment is a strong risk factor for the prevalence of MRSA in the hospitalized patients, visitors, and hospital staff with potential risk of spreading to the community.
    [Show full text]
  • Arthur Kornberg Discovered (The First) DNA Polymerase Four
    Arthur Kornberg discovered (the first) DNA polymerase Using an “in vitro” system for DNA polymerase activity: 1. Grow E. coli 2. Break open cells 3. Prepare soluble extract 4. Fractionate extract to resolve different proteins from each other; repeat; repeat 5. Search for DNA polymerase activity using an biochemical assay: incorporate radioactive building blocks into DNA chains Four requirements of DNA-templated (DNA-dependent) DNA polymerases • single-stranded template • deoxyribonucleotides with 5’ triphosphate (dNTPs) • magnesium ions • annealed primer with 3’ OH Synthesis ONLY occurs in the 5’-3’ direction Fig 4-1 E. coli DNA polymerase I 5’-3’ polymerase activity Primer has a 3’-OH Incoming dNTP has a 5’ triphosphate Pyrophosphate (PP) is lost when dNMP adds to the chain E. coli DNA polymerase I: 3 separable enzyme activities in 3 protein domains 5’-3’ polymerase + 3’-5’ exonuclease = Klenow fragment N C 5’-3’ exonuclease Fig 4-3 E. coli DNA polymerase I 3’-5’ exonuclease Opposite polarity compared to polymerase: polymerase activity must stop to allow 3’-5’ exonuclease activity No dNTP can be re-made in reversed 3’-5’ direction: dNMP released by hydrolysis of phosphodiester backboneFig 4-4 Proof-reading (editing) of misincorporated 3’ dNMP by the 3’-5’ exonuclease Fidelity is accuracy of template-cognate dNTP selection. It depends on the polymerase active site structure and the balance of competing polymerase and exonuclease activities. A mismatch disfavors extension and favors the exonuclease.Fig 4-5 Superimposed structure of the Klenow fragment of DNA pol I with two different DNAs “Fingers” “Thumb” “Palm” red/orange helix: 3’ in red is elongating blue/cyan helix: 3’ in blue is getting edited Fig 4-6 E.
    [Show full text]
  • Microbiological Air Quality and Drug Resistance in Airborne Bacteria Isolated from a Waste Sorting Plant Located in Poland—A Case Study
    microorganisms Article Microbiological Air Quality and Drug Resistance in Airborne Bacteria Isolated from a Waste Sorting Plant Located in Poland—A Case Study Ewa Br ˛agoszewska 1,* , Izabela Biedro ´n 2 and Wojciech Hryb 1 1 Faculty of Power and Environmental Engineering, Department of Technologies and Installations for Waste Management, Silesian University of Technology, 18 Konarskiego St., 44-100 Gliwice, Poland; [email protected] 2 Institute for Ecology of Industrial Areas, Environmental Microbiology Unit, 6 Kossutha St., 40-844 Katowice, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-322-372-762 Received: 13 December 2019; Accepted: 29 January 2020; Published: 31 January 2020 Abstract: International interests in biological air pollutants have increased rapidly to broaden the pool of knowledge on their identification and health impacts (e.g., infectious, respiratory diseases and allergies). Antibiotic resistance and its wider implications present us with a growing healthcare crisis, and an increased understanding of antibiotic-resistant bacteria populations should enable better interpretation of bioaerosol exposure found in the air. Waste sorting plant (WSP) activities are a source of occupational bacterial exposures that are associated with many health disorders. The objectives of this study were (a) to assess bacterial air quality (BAQ) in two cabins of a WSP: preliminary manual sorting cabin (PSP) and purification manual sorting cabin (quality control) (QCSP), (b) determine the particle size distribution (PSD) of bacterial aerosol (BA) in PSP, QCSP, and in the outdoor air (OUT), and (c) determine the antibiotic resistance of isolated strains of bacteria. Bacterial strains were identified on a Biolog GEN III (Biolog, Hayward, CA, USA), and disc diffusion method for antimicrobial susceptibility testing was carried out according to the Kirby–Bauer Disk Diffusion Susceptibility Test Protocol.
    [Show full text]
  • The Response to DNA Damage at Telomeric Repeats and Its Consequences for Telomere Function
    Review The Response to DNA Damage at Telomeric Repeats and Its Consequences for Telomere Function Ylli Doksani IFOM, The FIRC Institute of Molecular Oncology, via Adamello 16, 20139 Milan, Italy; [email protected]; Tel.: +39-02-574303258 Received: 26 March 2019; Accepted: 18 April 2019; Published: 24 April 2019 Abstract: Telomeric repeats, coated by the shelterin complex, prevent inappropriate activation of the DNA damage response at the ends of linear chromosomes. Shelterin has evolved distinct solutions to protect telomeres from different aspects of the DNA damage response. These solutions include formation of t-loops, which can sequester the chromosome terminus from DNA-end sensors and inhibition of key steps in the DNA damage response. While blocking the DNA damage response at chromosome ends, telomeres make wide use of many of its players to deal with exogenous damage and replication stress. This review focuses on the interplay between the end-protection functions and the response to DNA damage occurring inside the telomeric repeats, as well as on the consequences that telomere damage has on telomere structure and function. Keywords: telomere maintenance; shelterin complex; end-protection problem; telomere damage; telomeric double strand breaks; telomere replication; alternative lengthening of telomeres 1. Telomere Structure and End-Protection Functions Mammalian telomeres are made of tandem TTAGGG repeats that extend several kilobases and terminate with a 3′ single-stranded overhang about 50–400 nucleotides long. Telomeric repeats are coated in a sequence-specific fashion by a 6-protein complex named shelterin that prevents the activation of the Double Strand Break (DSB) response at chromosome ends [1-3].
    [Show full text]
  • Antibiotic Sensitivity of Bacterial Pathogens Isolated from Bovine Mastitis Milk
    Content of Research Report A. Project title: Antibiotic Sensitivity of Bacterial Pathogens Isolated From Bovine Mastitis Milk B. Abstract: Antibiotic sensitivity of bacteria isolated from bovine milk samples was investigated. The 18 antibiotics that were evaluated (e.g., penicillin, novobiocin, gentamicin) are commonly used to treat various diseases in cattle, including mastitis, an inflammation of the udder of dairy cows. A common concern in using antibiotics is the increase in drug resistance with time. This project studies if antibiotic resistance is a threat to consumers of raw milk products and if these antibiotics are still effective against mastitis pathogens. The study included isolating and culturing bacteria from quarter milk samples (n=205) collected from mastitic dairy cows from farms in Chino and Ontario, CA. The isolated bacteria were tested for sensitivity to antibiotics using the Kirby Bauer disk diffusion method. The prevalence (%) of resistance to the individual antibiotics was reported. Resistance to penicillin was 45% which may support previous data on penicillin-resistant bacteria, especially Staphylococcus and Streptococcus. Resistance rates (%) for oxytetracycline (26.8%) and tetracycline (22.9%) were low compared to previous studies but a trend was seen in our results that may support concerns of emerging resistance to tetracyclines in both gram- positive and gram-negative bacteria. Similarly, 31.9% of bacterial isolates showed resistance to erythromycin which is at least 30% less than in reported literature concerning emerging resistance to macrolides. More numbers (%) that should be noted are cefazolin (26.3%), ampicillin (29.7%), novobiocin (33.0%), polymyxin B (31.5%), and resistance ranging from 9­ 18% for the other antibiotics.
    [Show full text]
  • T4 DNA Ligase Protocol
    Certificate of Analysis T4 DNA Ligase: Part# 9PIM180 Size Part No. (Weiss units) M180A 100 Revised 4/18 M180B 500 M179A (High Conc.) 500 Ligase Buffer, 10X (C126A, C126B): The Ligase 10X Buffer supplied with this enzyme has a composition of 300mM Tris-HCl (pH 7.8), 100mM MgCl2, 100mM DTT and 10mM ATP. The performance of this buffer depends on the integrity of the ATP. Store the buffer in small aliquots at –20°C to minimize degradation of the ATP and DTT. *AF9PIM180 0418M180* Note: The DTT in the Ligase 10X Buffer may precipitate upon freezing. If this occurs, vortex the buffer until the precipitate AF9PIM180 0418M180 is in solution (typically 1–2 minutes). The performance of the product is not affected provided that the precipitate is resuspended. Enzyme Storage Buffer: T4 DNA Ligase is supplied in 10mM Tris-HCl (pH 7.4), 50mM KCl, 1mM DTT, 0.1mM EDTA and 50% glycerol. Source: E. coli strain expressing a recombinant clone. Unit Definition: 0.01 Weiss unit of T4 DNA Ligase is defined as the amount of enzyme required to catalyze the ligation of greater than 95% of the Hind III fragments of 1µg of Lambda DNA at 16°C in 20 minutes. See the unit concentration on the Product Information Label. Storage Temperature: Store at –20°C. Avoid multiple freeze-thaw cycles and exposure to frequent temperature changes. See the expiration date on the Product Information Label. Promega Corporation 2800 Woods Hollow Road Madison, WI 53711-5399 USA Quality Control Assays Telephone 608-274-4330 Toll Free 800-356-9526 Activity Assays Fax 608-277-2516 Internet www.promega.com Blue/White Assay: pGEM®-3Zf(+) Vector is digested with representative restriction enzymes (leaving 5´-termini, 3´-termini or blunt ends).
    [Show full text]
  • JOURNAL of BACTERIOLOGY VOLUME 169 DECEMBER 1987 NUMBER 12 Samuel Kaplan, Editor in Chief (1992) Kenneth N
    JOURNAL OF BACTERIOLOGY VOLUME 169 DECEMBER 1987 NUMBER 12 Samuel Kaplan, Editor in Chief (1992) Kenneth N. Timmis, Editor (1992) University of Illinois, Urbana Richard M. Losick, Editor (1988) Centre Medical Universitaire, James D. Friesen, Editor (1992) Harvard University, Cambridge, Mass. Geneva, Switzerland University of Toronto, L. Nicholas Ornston, Editor (1992) Graham C. Walker, Editor (1990) Toronto, Canada Yale University, New Haven, Conn. Massachusetts Institute of Stanley C. Holt, Editor (1987) Robert H. Rownd, Editor (1990) Technology, Cambridge, Mass. The University of Texas Health Northwestern Medical School, Robert A. Weisberg, Editor (1990) Science Center, San Antonio Chicago, Ill. National Institute of Child June J. Lascelles, Editor (1989) Health and Human University of California, Los Angeles Development, Bethesda, Md. EDITORIAL BOARD David Apirion (1988) James G. Ferry (1989) Eva R. Kashket (1987) Palmer Rogers (1987) Stuart J. Austin (1987) David Figurski (1987) David E. Kennell (1988) Barry P. Rosen (1989) Frederick M. Ausubel (1989) Timothy J. Foster (1989) Wil N. Konings (1987) Lucia B. Rothman-Denes (1989) Barbara Bachmann (1987) Robert T. Fraley (1988) Jordan Konisky (1987) Rudiger Schmitt (1989) Manfred E. Bayer (1988) David I. Friedman (1989) Dennis J. Kopecko (1987) June R. Scott (1987) Margret H. Bayer (1989) Masamitsu Futai (1988) Viji Krishnapillai (1988) Jane K. Setlow (1987) Claire M. Berg (1989) Robert Gennis (1988) Terry Krulwich (1987) Peter Setlow (1987) Helmut Bertrand (1988) Jane Gibson (1988) Lasse Lindahl (1987) James A. Shapiro (1988) Terry J. Beveridge (1988) Robert D. Goldman (1988) Jack London (1987) Louis A. Sherman (1988) Donald A. Bryant (1988) Susan Gottesman (1989) Sharon Long (1989) Howard A.
    [Show full text]